Olema Pharmaceuticals, Inc. (OLMA)
23.75
+0.10
(+0.42%)
USD |
NASDAQ |
Feb 12, 16:00
23.70
-0.05
(-0.21%)
After-Hours: 20:00
Olema Pharmaceuticals Free Cash Flow : -134.67M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Cidara Therapeutics, Inc. | -132.94M |
| Cogent Biosciences, Inc. | -246.73M |
| Corvus Pharmaceuticals, Inc. | -32.22M |
| Genprex, Inc. | -15.08M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.53M |
| Cash from Investing (Quarterly) | 17.27M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow Per Share (Quarterly) | -0.4027 |
| Free Cash Flow to Equity (Quarterly) | -34.25M |
| Free Cash Flow to Firm (Quarterly) | -34.53M |
| Free Cash Flow Yield | -6.85% |